# OnCo record nct07016230 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct07016230/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct07016230", "NCT07016230" ;
  schema:name "Study Investigating Tarlatamab (AMG 757) in Patients With Metastatic/Locally Advanced Small-Cell Lung Cancer (SCLC) and Other Poorly Differentiated Neuroendocri"@en ;
  schema:description "A phase 2 trial of tarlatamab in lung cancer, run by Gustave Roussy, Cancer Campus, Grand Paris, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct07016230/> ;
  schema:dateModified "2026-09-25"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT07016230> ;
  onco:status "recruiting" ;
  onco:tag "ctgov-ingest", "lung-deep-dive" ;
  onco:phase "2" ;
  onco:cancers <https://onco.cc/cancers/sclc/> ;
  onco:technologies <https://onco.cc/technologies/bispecific-antibody/>, <https://onco.cc/technologies/t-cell-engager/> ;
  onco:drugs <https://onco.cc/drugs/tarlatamab/> ;
  onco:companies <https://onco.cc/companies/amgen/> .